Xalkori and Disease progression - a phase IV clinical study of FDA data

Summary:

Disease progression is reported as a side effect among people who take Xalkori (crizotinib), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Lasix, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Disease progression when taking Xalkori. It is created by eHealthMe based on reports of 9,640 people who have side effects when taking Xalkori from the FDA, and is updated regularly.

What is Xalkori?

Xalkori has active ingredients of crizotinib. eHealthMe is studying from 9,659 Xalkori users. Check the latest studies of Xalkori.

What is Disease progression?

Disease progression is found to be associated with 1,801 drugs and 2,253 conditions by eHealthMe. Check the latest studies of Disease progression.

On Jul, 19, 2026

9,640 people reported to have side effects when taking Xalkori.
Among them, 1,010 people (10.48%) have Disease progression.

Could Xalkori cause Disease progression?

Among these 1,010 people:

How long have people been on Xalkori when they have Disease progression? *

Click here to view more results

What is the gender of people who have Disease progression when taking Xalkori? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Xalkori and have Disease progression?

- Check whether Disease progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xalkori:

Xalkori (9,659 reports)

Disease progression treatments and more:

Disease progression (115,298 reports)

How severe was Disease progression and when was it recovered:

Disease progression in Xalkori

Expand to all the drugs that have ingredients of crizotinib:

Disease progression and drugs with ingredients of crizotinib (1,296 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xalkori:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disease progression:

Disease progression (1,801 drugs)

Browse all the conditions that are associated with Disease progression:

Disease progression (2,253 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on crizotinib (the active ingredients of Xalkori) and Xalkori (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.